Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

Antimicrob Resist Infect Control. 2020 Jun 10;9(1):82. doi: 10.1186/s13756-020-00752-3.

Abstract

To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.

Keywords: Candida; Cross infection; Drug resistance; Risk factors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Bacterial Proteins / metabolism*
  • Canada / epidemiology
  • Candida / isolation & purification*
  • Candida / metabolism
  • Candidiasis / epidemiology*
  • Female
  • Humans
  • India
  • Male
  • Middle Aged
  • Prevalence
  • Travel
  • beta-Lactamases / metabolism*

Substances

  • Bacterial Proteins
  • beta-Lactamases
  • carbapenemase